Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 2/20 | 0.33 |
| ▸ | TRDMT1 | O14717 | 1/20 | 0.33 |
| ▸ | NNMT | P40261 | 5/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.32 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.32 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.32 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.32 |
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7920985 | 0.91 | P2RX3 (0.33) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL6895651 | 0.87 | AHCY (0.35) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL6898692 | 0.87 | AHCY (0.35) | CARM1TRDMT1NNMTDOT1L | |
| SCHEMBL7050370 | 0.87 | NNMT (0.34) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL7914645 | 0.87 | TRDMT1 (0.37) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL4557136 | 0.85 | NNMT (0.34) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL5501797 | 0.83 | CARM1 (0.33) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL2109084 | 0.82 | TRDMT1 (0.36) | CARM1TRDMT1NNMTDOT1LTYMP | |
| SCHEMBL5403467 | 0.82 | TRDMT1 (0.35) | CARM1TRDMT1NNMTP2RX3P2RX4 | |
| SCHEMBL15879332 | 0.81 | TRDMT1 (0.36) | CARM1TRDMT1NNMTDOT1LTYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6262241-B1 | ANTISENSE COMPOUNDS WHICH CLEAVE PHOSPHORODIESTER BONDS AND IMPROVE PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF OLIGONUCLEOTIDES, USEFUL IN DIAGNOSING DISEASES | ISIS PHARMACEUTICALS, INC. | 2001-07-17 | — | — | US | disclosed |